Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Hauser

Showing results (271-280 of 322) with videos related to

Pageof 33
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|March 13, 2026
Development of a Diagnostic Autoantibody Assay to a Consensus Motif for the Risk Prediction of Epstein-Barr Virus-Related Multiple SclerosisKrista M McCutcheon, Aaron Bodansky, Thomas T Ngo, et al.
Lancet (London, England)|May 28, 2026
Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trialsStephen L Hauser, Gavin Giovannoni, Xavier Montalban, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2018
Harnessing electronic medical records to advance research on multiple sclerosisVincent Damotte, Antoine Lizée, Matthew Tremblay, et al.
The New England Journal of Medicine|July 31, 2007
Risk alleles for multiple sclerosis identified by a genomewide study, David A Hafler, Alastair Compston, et al.
Human Molecular Genetics|July 9, 2004
Enhancing linkage analysis of complex disorders: an evaluation of high-density genotypingStephen J Sawcer, Mel Maranian, Sara Singlehurst, et al.
Science (New York, N.Y.)|December 5, 2024
Programming tissue-sensing T cells that deliver therapies to the brainMilos S Simic, Payal B Watchmaker, Sasha Gupta, et al.
Multiple Sclerosis and Related Disorders|November 24, 2023
Patient-reported outcome parameters and disability worsening in progressive multiple sclerosisAhmed Abdelhak, Kai Antweiler, Markus C Kowarik, et al.
Molecular Autism|April 5, 2012
Evidence of novel fine-scale structural variation at autism spectrum disorder candidate lociDale J Hedges, Kara L Hamilton-Nelson, Stephanie J Sacharow, et al.
European Journal of Neurology|March 16, 2021
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registryHelmut Butzkueven, Tim Spelman, Dana Horakova, et al.
Annals of Neurology|September 30, 2014
Precision medicine in chronic disease management: The multiple sclerosis BioScreenPierre-Antoine Gourraud, Roland G Henry, Bruce A C Cree, et al.
Pageof 33

Showing results (271-280 of 322) with videos related to

Sort By:
Pageof 33
Neurology(R) Neuroimmunology & Neuroinflammation|March 13, 2026
Development of a Diagnostic Autoantibody Assay to a Consensus Motif for the Risk Prediction of Epstein-Barr Virus-Related Multiple SclerosisKrista M McCutcheon, Aaron Bodansky, Thomas T Ngo, et al.
Lancet (London, England)|May 28, 2026
Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trialsStephen L Hauser, Gavin Giovannoni, Xavier Montalban, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2018
Harnessing electronic medical records to advance research on multiple sclerosisVincent Damotte, Antoine Lizée, Matthew Tremblay, et al.
The New England Journal of Medicine|July 31, 2007
Risk alleles for multiple sclerosis identified by a genomewide study, David A Hafler, Alastair Compston, et al.
Human Molecular Genetics|July 9, 2004
Enhancing linkage analysis of complex disorders: an evaluation of high-density genotypingStephen J Sawcer, Mel Maranian, Sara Singlehurst, et al.
Science (New York, N.Y.)|December 5, 2024
Programming tissue-sensing T cells that deliver therapies to the brainMilos S Simic, Payal B Watchmaker, Sasha Gupta, et al.
Multiple Sclerosis and Related Disorders|November 24, 2023
Patient-reported outcome parameters and disability worsening in progressive multiple sclerosisAhmed Abdelhak, Kai Antweiler, Markus C Kowarik, et al.
Molecular Autism|April 5, 2012
Evidence of novel fine-scale structural variation at autism spectrum disorder candidate lociDale J Hedges, Kara L Hamilton-Nelson, Stephanie J Sacharow, et al.
European Journal of Neurology|March 16, 2021
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registryHelmut Butzkueven, Tim Spelman, Dana Horakova, et al.
Annals of Neurology|September 30, 2014
Precision medicine in chronic disease management: The multiple sclerosis BioScreenPierre-Antoine Gourraud, Roland G Henry, Bruce A C Cree, et al.
Pageof 33